Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) IPO

Telomir Pharmaceuticals, Inc.

IPO

Priced at US$7.00 a share on Feb 8, 2024.

Price
US$7.00 a share
Shares offered
1,000,000 shares of common stock
Offering size
US$7 million
Underwriters' option
Up to 150,000 more shares
Listing
TELO on the Nasdaq Capital Market
Underwriter
Kingswood Investments
Shares delivered
On or about Feb 13, 2024

Steps

StepWhen
Draft sent to the SEC in confidenceAug 14, 2023
Filed publiclyNov 14, 2023
Amended 3 timesNewest Jan 3, 2024
Shares registered with an exchangeFeb 6, 2024
Declared effective by the SECFeb 8, 2024
Final prospectus, with the priceFeb 12, 2024

From the cover of the final prospectus (424B1) filed Feb 12, 2024